Mitral Valve Edge to Edge Repair for Papillary Muscle Rupture after Acute Myocardial Infarction

With an approximate incidence of 0.05% to 0.25%, post-acute myocardial infarction (AMI) mitral valve failure caused by papillary muscle rupture is not exactly common. However, it is associated to high mortality rate, ranging between 36% and 80%.

Tratamiento borde a borde de la válvula mitral por ruptura del músculo papilar en el infarto agudo de miocardio

Current guidelines recommend surgical treatment, but more often than not surgery involves prohibitive or extremely high risk, with mortality ranging between 21% and 53%, according to the available reports. 

Edge-to-edge repair has been shown safe, effective and beneficial, and could be considered a viable strategy in this scenario. However, there is little information about it. 

This study looked at 22 patients presenting complicated AMI with papillary muscle rupture, 17 of these caused by ST elevation MI.

Mean patient age was 74, 13 were men, 10 saw complete papillary muscle rupture and 15 were affected in their posteromedial muscle. 19 presented cardiogenic shock, 3 developed acute lung edema, 16 received inotropics and they were all using ventricular assisting devices. 

Read also: Secondary Prevention with P2Y12 Inhibitors: How Consolidated Is This Long Term Alternative vs. Aspirin?

MitraClip implantation was successful in all patients, and 17 of them received 2 clips. No patient presented moderate to severe mitral valve regurgitation (MR) and there was average residual gradient 3.7 mmHg.

During hospital stay, 4 patients died (2 because of sepsis and 2 for cardiac failure) and one patient suffered a stroke. 

14 patients were followed up for mean 2.5 months (from 1 to 6 months) During this time, 2 patients died and 2 presented moderate MR, but no patient developed severe MR. 

Conclusion

This analysis has shown edge-to-edge repair is safe and effective for post-AMI mitral regurgitation management. This series of cases informs a significant reduction in MR severity, with relatively low inhospital death and a low rate of complications. Long term outcome assessment calls for further dedicated studies. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the editorial board of SOLACI.org.

Original Title: Transcatheter edge‐to‐edge mitral valve repair for post‐myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...